On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Royal Hobart Hospital

InstitutionResearch output, impact & collaborations

Royal Hobart Hospital is a institution indexed in ScholarIQ from OpenAlex.

What is known about Royal Hobart Hospital?

ScholarIQrecord summary

Royal Hobart Hospital is a research organisation in Hobart, AU. OpenAlex records 3,971 works and 147,020 citations for it. 1,016 researchers list it as their most recent affiliation.

How many works does Royal Hobart Hospital have?

ScholarIQindexed works

Royal Hobart Hospital has 3,971 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Royal Hobart Hospital →

How many citations does Royal Hobart Hospital have?

ScholarIQcitation count

Royal Hobart Hospital has 147,020 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Royal Hobart Hospital →

How many researchers are at Royal Hobart Hospital?

ScholarIQresearcher count

Royal Hobart Hospital has 1,016 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Royal Hobart Hospital?

ScholarIQavg h-index

Royal Hobart Hospital has an average h-index of 63 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Royal Hobart Hospital?

ScholarIQror

The ROR for Royal Hobart Hospital is on the source record.

Open the ROR →

What is the OpenAlex record for Royal Hobart Hospital?

ScholarIQopenalex

The OpenAlex for Royal Hobart Hospital is on the source record.

Open the OpenAlex →

What is the Wikidata of Royal Hobart Hospital?

ScholarIQwikidata

The Wikidata for Royal Hobart Hospital is on the source record.

Open the Wikidata →

Who are the most-cited researchers behind Royal Hobart Hospital?

ScholarIQtop researchers by citations

Timothy Price · Colorectal Cancer Treatments and Studies

774 works34,639 citations

What are the most-cited papers on Royal Hobart Hospital?

ScholarIQmost cited works

Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation

Ferdinandos Skoulidis, Bob T. Li, Grace K. Dy, Timothy Price, Gerald S. Falchook, Jürgen Wolf, Antoîne Italiano, Martin Schüler, Hossein Borghaei, Fabrice Barlési, Terufumi Kato, Alessandra Curioni‐Fontecedro, Adrian G. Sacher, Alexander I. Spira, Suresh S. Ramalingam, Toshiaki Takahashi, Benjamin Besse, Abraham Anderson, Agnes Ang, Qui Tran, Omar Mather, Haby Henary, Gataree Ngarmchamnanrith, Gregory Friberg, Vamsidhar Velcheti, Ramaswamy Govindan

New England Journal of Medicine. 20211,810 CitationsOPEN ACCESS

KRAS <sup>G12C</sup> Inhibition with Sotorasib in Advanced Solid Tumors

David S. Hong, Marwan Fakih, John H. Strickler, Jayesh Desai, Gregory A. Durm, Geoffrey I. Shapiro, Gerald S. Falchook, Timothy Price, Adrian G. Sacher, Crystal S. Denlinger, Yung‐Jue Bang, Grace K. Dy, John C. Krauss, Yasutoshi Kuboki, James Kuo, Andrew L. Coveler, Keunchil Park, Tae Won Kim, Fabrice Barlési, Pamela N. Münster, Suresh S. Ramalingam, Timothy F. Burns, Funda Meric‐Bernstam, Haby Henary, Jude Ngang, Gataree Ngarmchamnanrith, June Myung Kim, Brett E. Houk, Jude Canon, J. Russell Lipford, Gregory Friberg, Piro Lito, Ramaswamy Govindan, Bob T. Li

New England Journal of Medicine. 20201,718 CitationsOPEN ACCESS

Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy

Vignesh Narasimhan, Josephine A. Wright, Michael Churchill, Tongtong Wang, Rachele Rosati, Tamsin R.M. Lannagan, Laura Vrbanac, Anne B. Richardson, Hiroki Kobayashi, Timothy Price, Gayle X.Y. Tye, Julie Marker, Peter J. Hewett, Michael P. Flood, Shalini Pereira, G. Adam Whitney, Michael Michael, Jeanne Tie, Siddhartha Mukherjee, Carla Grandori, Alexander G. Heriot, Daniel L. Worthley, Robert G. Ramsay, Susan L. Woods

Clinical Cancer Research. 2020185 CitationsOPEN ACCESS

How much of the research on Royal Hobart Hospital is open access?

ScholarIQopen access share

100%OPEN ACCESS

Gold

Green

67%

Hybrid

Bronze

33%

Closed